ISIN No
|
INE711D01018
|
BSE Code / NSE Code
|
524516 / BACPHAR
|
Book Value (Rs.)
|
0.98
|
Face Value
|
10.00
|
Bookclosure
|
16/09/2023
|
52Week High
|
44
|
EPS
|
0.00
|
P/E
|
0.00
|
Market Cap.
|
26.18 Cr.
|
52Week Low
|
5
|
P/BV / Div Yield (%)
|
45.44 / 0.00
|
Market Lot
|
1.00
|
Security Type
|
Other
|
|
The company history sections lists out major chronological events that happened to the company.
Bacil Pharma Ltd as incorporated as a P Ltd company in the State Maharashtra onm 8th May 1987. It has been converted into public Ltd company on 19.9.90 and obtained fresh certificate of incorporation consequent to the change of name on 26.10.93. There has been no business acitivity since incorporation. The main promoter of the company is Mr. Prakash Shah.
The company is implementing a project to manufacture Bulk drugs viz, Atenalol, Ciprofloxacin, Pefloxacain, Mesylate, Norfloxacin and Para Hydroxy Phenyl Acetamide.
2008
- Bacil Pharma - E-mail ID for Investor Grievances is bacilpha@yahoo.com.
|